These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2002 related articles for article (PubMed ID: 33942327)

  • 1. Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia.
    Camou F; Tinevez C; Beguet-Yachine M; Bellecave P; Ratiarison D; Tumiotto C; Lafarge X; Guisset O; Mourissoux G; Lafon ME; Bonnet F; Issa N
    J Med Virol; 2021 Sep; 93(9):5594-5598. PubMed ID: 33942327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
    Nomoto H; Kutsuna S; Okuma K; Kuramitsu M; Tezuka K; Ikebe E; Saito S; Kinoshita N; Terada M; Endo M; Suzuki T; Miyazato Y; Nakamoto T; Inada M; Hamaguchi I; Ohmagari N
    J Infect Chemother; 2021 Apr; 27(4):653-655. PubMed ID: 33487533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Kimura M; Yamada H; Sakamaki I; Yamamoto Y
    J Med Virol; 2022 Jan; 94(1):147-153. PubMed ID: 34411312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.
    Tang K; Wu L; Luo Y; Gong B
    J Med Virol; 2021 May; 93(5):3165-3175. PubMed ID: 33590923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
    Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
    Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study.
    Destremau M; Chaussade H; Hemar V; Beguet M; Bellecave P; Blanchard E; Barret A; Laboure G; Vasco-Moynet C; Lacassin F; Morisse E; Aguilar C; Lafarge X; Lafon ME; Bonnet F; Issa N; Camou F
    J Med Virol; 2024 Apr; 96(4):e29603. PubMed ID: 38619025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients.
    Järhult JD; Hultström M; Bergqvist A; Frithiof R; Lipcsey M
    Sci Rep; 2021 Mar; 11(1):7163. PubMed ID: 33785784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma.
    Tedim AP; Almansa R; Domínguez-Gil M; González-Rivera M; Micheloud D; Ryan P; Méndez R; Blanca-López N; Pérez-García F; Bustamante E; Gómez JM; Doncel C; Trapiello W; Kelvin AA; Booth R; Ostadgavahi AT; Oneizat R; Puertas C; Barbé F; Ferrer R; Menéndez R; Bermejo-Martin JF; Eiros JM; Kelvin DJ; Torres A
    Eur J Clin Invest; 2021 Jun; 51(6):e13501. PubMed ID: 33512013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
    Hogan CA; Stevens BA; Sahoo MK; Huang C; Garamani N; Gombar S; Yamamoto F; Murugesan K; Kurzer J; Zehnder J; Pinsky BA
    Clin Infect Dis; 2021 May; 72(9):e291-e295. PubMed ID: 32965474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19.
    Kim DM; Lawrence Panchali MJ; Kim CM; Lee DY; Seo JW; Kim DY; Yun NR
    Sci Rep; 2024 Jun; 14(1):14926. PubMed ID: 38942808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.
    Omrani AS; Zaqout A; Baiou A; Daghfal J; Elkum N; Alattar RA; Bakdach D; Abusriwil H; Mostafa AM; Alhariri B; Ambra N; Khatib M; Eldeeb AM; Merenkov Z; Fawzi Z; Hmissi SM; Hssain AA; Coyle PV; Alsoub H; Almaslamani MA; Alkhal A
    J Med Virol; 2021 Mar; 93(3):1678-1686. PubMed ID: 32965715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convalescent plasma therapy against the emerging SARS-CoV-2 variants: Delineation of the potentialities and risks.
    Dhawan M; Priyanka ; Parmar M; Angural S; Choudhary OP
    Int J Surg; 2022 Jan; 97():106204. PubMed ID: 34974199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.
    Jacobs JL; Bain W; Naqvi A; Staines B; Castanha PMS; Yang H; Boltz VF; Barratt-Boyes S; Marques ETA; Mitchell SL; Methé B; Olonisakin TF; Haidar G; Burke TW; Petzold E; Denny T; Woods CW; McVerry BJ; Lee JS; Watkins SC; St Croix CM; Morris A; Kearney MF; Ladinsky MS; Bjorkman PJ; Kitsios GD; Mellors JW
    Clin Infect Dis; 2022 May; 74(9):1525-1533. PubMed ID: 34374761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and Clinical Outcomes in Children With Coronavirus Disease 2019.
    Mertz C; Glowinski R; Cohen SH; Mertz S; Ye F; Hall MW; Peeples ME; King T; Wang H; Leber AL; Sanchez PJ; Ramilo O; Mejias A
    J Infect Dis; 2022 Jan; 225(2):208-213. PubMed ID: 34618885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients.
    Eberhardt KA; Meyer-Schwickerath C; Heger E; Knops E; Lehmann C; Rybniker J; Schommers P; Eichenauer DA; Kurth F; Ramharter M; Kaiser R; Holtick U; Klein F; Jung N; Di Cristanziano V
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers.
    Olea B; Albert E; Torres I; Gozalbo-Rovira R; Carbonell N; Ferreres J; Poujois S; Costa R; Colomina J; Rodríguez-Díaz J; Blasco ML; Navarro D
    J Med Virol; 2022 Jan; 94(1):222-228. PubMed ID: 34449894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for COVID-19 mortality: The effect of convalescent plasma administration.
    Salazar MR; González SE; Regairaz L; Ferrando NS; González Martínez VV; Carrera Ramos PM; Muñoz L; Pesci SA; Vidal JM; Kreplak N; Estenssoro E
    PLoS One; 2021; 16(4):e0250386. PubMed ID: 33914780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.